Sue Kozij (secretary) and Catherine Wormald (chairperson) attended the Endocrine Society of Australian (ESA) and the Endocrine Nurses Society of Australia (ENSA) Conferences on the Gold Coast in August.
The APF had a trade display at the conference and the conference participants showed much interest. Representatives of many hospitals requested posters to display in their clinics and waiting rooms. Some doctors also expressed an interest in finding out more about the Foundation and the work it did. The conferences provides an opportunity for Sue and Catherine to network and make contacts with a variety of people and the possibility of discussing further sponsorship with the pharmaceutical companies. Although very exhausting for Sue and Catherine they were very worthwhile from the perspective of the APF.
Kel Childs (member) and Catherine Wormald presented to the nurses of ENSA on the male perspective when dealing with pituitary illness and on the work of the Foundation. The nurses were an extremely receptive audience and asked many questions. They found the session very informative. ENSA also donated $150 to the APF in recognition of the time given by the presenters.

Kel Childs presented a male perspective of living with pituitary disease
The nurses from ENSA were very welcoming and encouraging. Many of us are aware of the great work the nurses do and the practical strategies they offer. Sue and Catherine would like to thank ENSA for their very warm welcome and hospitality. The ESA were also supportive of the APF and it was as a result of their goodwill that the foundation was able to have a trade table. The APF is looking forward to continuing these partnerships.

Kel Childs (APF member), Catherine Wormald (APF Chairperson), Jill Stillman (Senior Research Assistant, Centre for Online Health, University of Queensland, Executive Secretary and Organizing Chair for the ENSA Annual Conference), and Klaus Sommer Endocrine CNC, Dept. of Endocrinology and Metabolism, Concord Hospital, Treasurer ENSA)
As well as attending these conferences the APF also had representation at the Australian Paediatric Endocrine Group (APEG) Scientific Meeting in September in Hobart. As the Children’s Growth Foundation merged with the APF several years ago this was a golden opportunity for awareness of the APF to be raised amongst paediatricians.
Providing for our members who are children is a high priority for the APF. This scientific meeting also provided a chance to raise the issue of growth hormone for adults, as many of the foundations’ paediatric members who are on growth hormone, are, or will be becoming adults in the near future and this will become an issue of real concern for them and their families. We are pleased to say that this issue is very much a priority of the foundation and we will be doing our utmost to encourage and work with the pharmaceutical companies to submit another application to the government. The APF is grateful to the APEG committee, especially Dr Tricia Crock, who is very enthusiastic about the APF and the benefits for her patients. The APF would like to thank APEG for their generous support and we look forward to developing and furthering this partnership.